Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
['Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer', 'breast neoplasm', 'Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.', 'English', 'Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer']